Multisystem adverse drug events of low-dose tirzepatide in a normal - Weight individual: A case report and literature review
We report a case of multisystem adverse drug events in a 19-year-old female with a normal body mass index (BMI, 22.23 kg/m 2 ) following a subcutaneous injection of 0.5 mg tirzepatide. Gastrointestinal symptoms appeared within 2 hours of administration, progressing to involve cardiovascular and renal systems over t...